UPS, FedEx and logistics giants are investing in the healthcare boom
Logistics giants UPS and FedEx are investing heavily in temperature-controlled infrastructure to support the growing demand for specialized pharmaceuticals like GLP-1 weight-loss drugs. This shift reflects the increasing importance of cold-chain logistics in the healthcare sector.
Why it matters
The expansion of cold-chain logistics is critical for the efficacy of modern biologics and represents a major growth area for the global shipping industry.
As demand rises for specialized medications like GLP-1s, logistics companies including UPS and FedEx are adapting their strategies to be able to better ship and store those pharmaceuticals.
Most injectable GLP-1 medications, including Novo Nordisk 's Ozempic and Wegovy and Eli Lilly 's Mounjaro and Zepbound, require refrigerated storage for shipment.
The Covid pandemic put healthcare logistics at center stage in 2020, as the shipping of temperature-controlled vaccines quickly became a crucial part of keeping the virus at bay. And as more money has been poured into new pharmaceutical innovations, the transportation of those products have come under the spotlight.
Logistics companies are now investing millions of dollars and strengthening dozens of temperature-controlled facilities to tap into the market.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in